These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1467 related articles for article (PubMed ID: 3159021)

  • 21. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a stable fragment of the Alzheimer amyloid precursor containing the beta-protein in brain microvessels.
    Tamaoka A; Kalaria RN; Lieberburg I; Selkoe DJ
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1345-9. PubMed ID: 1531538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The blood-brain barrier in Alzheimer's disease.
    Vinters HV; Pardridge WM
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):446-8. PubMed ID: 2947668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.
    Joachim CL; Mori H; Selkoe DJ
    Nature; 1989 Sep; 341(6239):226-30. PubMed ID: 2528696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuritic plaque amyloid in Alzheimer's disease is highly racemized.
    Shapira R; Austin GE; Mirra SS
    J Neurochem; 1988 Jan; 50(1):69-74. PubMed ID: 3121789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain amyloid and Alzheimer disease.
    Vinters HV; Miller BL; Pardridge WM
    Ann Intern Med; 1988 Jul; 109(1):41-54. PubMed ID: 3288032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Heinrich G
    N Engl J Med; 1989 Oct; 321(17):1197. PubMed ID: 2571933
    [No Abstract]   [Full Text] [Related]  

  • 28. Down syndrome and Alzheimer disease.
    Hyman BT
    Prog Clin Biol Res; 1992; 379():123-42. PubMed ID: 1409740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
    Coria F; Castaño EM; Frangione B
    Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins.
    Harper JD; Lansbury PT
    Annu Rev Biochem; 1997; 66():385-407. PubMed ID: 9242912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down syndrome as a key to the time sequence of brain changes in Alzheimer disease.
    Tagliavini F; Giaccone G; Verga L; Frangione B; Bugiani O
    Prog Clin Biol Res; 1992; 379():143-58. PubMed ID: 1409741
    [No Abstract]   [Full Text] [Related]  

  • 32. The amyloid deposits in Alzheimer's disease: their nature and pathogenesis.
    Glenner GG; Wong CW; Quaranta V; Eanes ED
    Appl Pathol; 1984; 2(6):357-69. PubMed ID: 6242724
    [No Abstract]   [Full Text] [Related]  

  • 33. Preamyloid deposits, amyloid deposits, and senile plaques in Alzheimer's disease, Down syndrome, and aging.
    Bugiani O; Tagliavini F; Giaccone G
    Ann N Y Acad Sci; 1991; 640():122-8. PubMed ID: 1837976
    [No Abstract]   [Full Text] [Related]  

  • 34. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.
    Coria F; Castaño E; Prelli F; Larrondo-Lillo M; van Duinen S; Shelanski ML; Frangione B
    Lab Invest; 1988 Apr; 58(4):454-8. PubMed ID: 2965774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An antiserum to the C-terminus of the Alzheimer amyloid precursor recognizes a soluble 70 kDa protein.
    Simpson J; Bladon CM; Yates CM; Harmar AJ
    FEBS Lett; 1988 Sep; 237(1-2):196-8. PubMed ID: 2971568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
    Ikeda S; Allsop D; Glenner GG
    Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On causative theories in Alzheimer's disease.
    Glenner GG
    Hum Pathol; 1985 May; 16(5):433-5. PubMed ID: 3157634
    [No Abstract]   [Full Text] [Related]  

  • 38. Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques.
    Iwatsubo T; Saido TC; Mann DM; Lee VM; Trojanowski JQ
    Am J Pathol; 1996 Dec; 149(6):1823-30. PubMed ID: 8952519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 31 kilodalton beta-protein immunoreactive polypeptide in neuronal lipofuscin.
    Bancher C; Grundke-Iqbal I; Iqbal K; Kim KS; Wisniewski HM
    Prog Clin Biol Res; 1989; 317():913-24. PubMed ID: 2690128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides.
    Robakis NK; Ramakrishna N; Wolfe G; Wisniewski HM
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4190-4. PubMed ID: 3035574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 74.